USPTO serial 79393432
DRUG DISCOVERY AI FACTORY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 28, 2025
- Examiner
- PARKS, KIMBERLY L
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DRUG DISCOVERY AI FACTORY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Tomoko Nakajima
Tomoko Nakajima Future IP LLC4315 50th Street NW, Suite 100 #77771-4, Kojimachi,Washington, DC 20016Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer programs for selecting target molecules and genes for the purpose of developing and creating drugs; downloadable computer programs for hypothesis generation regarding some relationships between target molecules and diseases for the purpose of developing and creating drugs; downloadable computer programs for hypothesis generation regarding some relationships between genes and diseases for the purpose of developing and creating drugs; downloadable computer programs for proposing and searching indications; downloadable computer programs for hypothesis generation regarding some relationships between certain modalities and their indications; devices for analyzing electronic images; downloadable computer programs for data processing; devices for data processing; computer hardware for data processing | ACTIVE | — |
| 035 | Compilation of information into computer databases for research in the field of pharmaceuticals | ACTIVE | — |
| 041 | Providing information on educational and instruction services relating to medicine and pharmaceuticals; arranging and conducting seminars relating to medicine and pharmaceuticals; instruction services in the field of pharmaceuticals | ACTIVE | — |
| 042 | Providing on-line non-downloadable computer programs for selecting target molecules and genes for the purpose of developing and creating drugs; providing on-line non-downloadable computer programs for hypothesis generation regarding some relationships between target molecules and diseases for the purpose of developing and creating drugs; providing on-line non-downloadable computer programs for hypothesis generation regarding some relationships between genes and diseases for the purpose of developing and creating drugs; providing on-line non-downloadable computer programs for proposing and searching indications; providing on-line non-downloadable computer programs for hypothesis generation regarding some relationships between certain modalities and their indications; provision of information search engines via internet; designing and creating services of home pages and websites; designing, programming, and maintenance of computer programs for selecting target molecules and genes for the purpose of developing and creating drugs; designing, programming, and maintenance of computer programs for hypothesis generation regarding some relationships between target molecules and diseases for the purpose of developing and creating drugs; designing, programming, and maintenance of computer programs for hypothesis generation regarding some relationships between genes and diseases for the purpose of developing and creating drugs; designing, programming, and maintenance of computer programs for proposing and searching indications; designing, programming, and maintenance of computer programs for hypothesis generation regarding some relationships between certain modalities and their indications; scientific testing, inspection and research for making a hypothesis on relationships between genes and diseases; testing, inspection or research of pharmaceuticals; consulting services relating to testing, inspection and research of pharmaceuticals; providing information on research of pharmaceuticals; drug discovery services; research and scientific inspection of pharmaceuticals relating to genetic analysis; scientific testing and research on health equipment; rental of measuring and testing instruments; rental of measuring apparatus; hosting web portals on the Internet; rental of server memory space for social networking websites; rental of computers | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by FRONTEO, Inc.
- Other trademarks owned by FRONTEO, Inc.
- Other trademarks owned by FRONTEO, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named DRUG DISCOVERY AI FACTORY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 11, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 26, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 26, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 5, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 15, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 15, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 29, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 28, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 28, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 10, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 10, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 4, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 14, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 4, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 4, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 4, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 18, 2024 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Aug 25, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 7, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 7, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 21, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 20, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 11, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 30, 2024 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Apr 23, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 18, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 16, 2024 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Apr 11, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |